newsfilter
← Latest News
Business Wire·

Eiger BioPharmaceuticals Announces Leadership Change

President and CEO David A. Cory resigns from the company effective immediately Dr. David Apelian named Interim CEO Eiger BioPharmaceuticals, Inc. ("Eiger" or "the company") (NASDAQ:EIGR), a commercial-stage